Insider · CIK 0001765212
Xiaoping Chen
Files at VIOT (Viomi Technology Co., Ltd). First filing -, latest -.
Xiaoping Chen files SEC Form 4 as CEO, director and 10% owner at VIOT (Viomi Technology Co., Ltd). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Xiaoping Chen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | VIOT Viomi Technology Co., Ltd | JOther Class A ordinary sharesindirect: By Viomi Limited | -2,200,000 | - | - | 0 | 4 d ago |
| Oct 8, 2026 | VIOT Viomi Technology Co., Ltd | JOther Class B ordinary sharesindirect: By Viomi Limited | -6,800,000 | - | - | 60,836,364 | 4 d ago |
| Oct 8, 2026 | VIOT Viomi Technology Co., Ltd | JOther American depositary sharesindirect: By Viomi Limited | +3,000,000 | - | - | 3,000,000 | 4 d ago |
Questions about Xiaoping Chen
Answered from the filings on this page, as of the latest one.
Is Xiaoping Chen buying or selling?
Xiaoping Chen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Xiaoping Chen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Xiaoping Chen has 0.
Where does Xiaoping Chen file Form 4?
Xiaoping Chen has filed Form 4 at VIOT (Viomi Technology Co., Ltd) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.